Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 18, 2026
Context: This filing serves as a cover document to submit an "Intimation" (Exhibit 99.1) dated February 18, 2026. The registrant is a foreign private issuer filing under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural cover sheet and does not contain financial statements or performance data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to regulatory signatures and exhibit descriptions.
Key Facts for Investor Verification
- The filing is a Form 6-K submitted on February 18, 2026, primarily to attach an "Intimation" document.
- The specific content of the "Intimation" (Exhibit 99.1) is not detailed in the provided text; investors must review the attached exhibit for material event details.
- The registrant files annual reports under Form 20-F.
- The filing was signed by K Randhir Singh, Company Secretary.